ArticleScientific reports2026
Physiologically based ferritin thresholds to redefine early pregnancy iron screening: a cross-sectional study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ferritin as a diagnostic point-of-care marker in iron deficiency anemia: a narrative review and clinical implications.Annals of translational medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Iron deficiency in early pregnancy is common yet frequently missed because current screening strategies rely on ferritin cutoffs designed to detect iron deficiency anemia. We aimed to establish physiologically based ferritin functional reference limits (FRLs) in healthy, non-anemic pregnant women, specifically to model early iron insufficiency prior to the onset of anemia, where screening strategies are most clinically actionable. The study was conducted at a maternity hospital in Ho Chi Minh City, Vietnam, enrolling first-trimester pregnant women. Participants were included if they had hemoglobin ≥ 11 g/dL, no evidence of infection, body-mass index (BMI) < 30 kg/m², and no confirmed hemoglobinopathies or unexplained microcytosis/hypochromia. The primary outcome was the ferritin FRLs, defined using restricted cubic spline modelling of standalone erythrocyte indices (MCV, MCH, HGB, and RDW). Diagnostic performance was assessed against TSAT. A total of 452 participants had complete data for validation. The final suggested ferritin FRL is 59 ng/mL, which identified more women with non-anemic iron deficiency compared with traditional cutoffs. Validation against TSAT showed excellent rule-out performance with a negative predictive value of 95.8%. A four-zone classification for iron deficiency emerged, including absolute deficiency (< 15 ng/mL), early-stage deficiency (15-26 ng/mL), transitional state (26-59 ng/mL), and physiologic sufficiency (≥ 59 ng/mL). Physiologically derived ferritin thresholds identify early iron deficiency more effectively than conventional cutoffs and provide a grounded framework for screening in the first trimester.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.